scholarly article | Q13442814 |
P50 | author | Stephen E. Harding | Q7609121 |
Mary K Phillips-Jones | Q42292302 | ||
Alan R Mackie | Q56419948 | ||
Gary G Adams | Q56855577 | ||
Vlad Dinu | Q58403612 | ||
Ryan Lithgo | Q59701113 | ||
Amelia Torcello-Gómez | Q85259450 | ||
Carlos Sabater | Q86495195 | ||
Guy Channell | Q125292857 | ||
Ian Fisk | Q38800117 | ||
P2093 | author name string | Nicola Weston | |
Christopher Parmenter | |||
Yudong Lu | |||
Hayley Coupe | |||
P2860 | cites work | Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 | Q24671879 |
Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues | Q26738728 | ||
Intestinal permeability--a new target for disease prevention and therapy | Q27015884 | ||
Optimizing the Clinical Use of Vancomycin | Q28069334 | ||
Bibliography of environmental scanning electron microscopy | Q28264079 | ||
Characterization of pig colonic mucins | Q42129436 | ||
Vancomycin Ototoxicity in a Patient with Normal Renal Function | Q42269595 | ||
A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient | Q42283854 | ||
Hydrodynamics of the VanA-type VanS histidine kinase: an extended solution conformation and first evidence for interactions with vancomycin | Q42292297 | ||
Physicochemical studies on turnip-yellow-mosaic virus. Homogeneity, relative molecular masses, hydrodynamic radii and concentration-dependence of parameters in non-dissociating solvents | Q42866803 | ||
Molecular weight distribution analysis by ultracentrifugation: adaptation of a new approach for mucins | Q43501326 | ||
An NMR study of eremomycin and its derivatives. Full 1H and 13C assignment, motional behavior, dimerization and complexation with Ac-D-Ala-D-Ala | Q43732873 | ||
Isolation and characterization of the native glycoprotein from pig small-intestinal mucus | Q43973097 | ||
Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. | Q45110091 | ||
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections | Q45127594 | ||
Mucus models to evaluate the diffusion of drugs and particles. | Q46265634 | ||
A prospective trial on the use of trough concentration versus area under the curve (AUC) to determine therapeutic vancomycin dosing | Q46731557 | ||
A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants | Q47183620 | ||
Effects of counterion size on the attraction between similarly charged surfaces | Q47402118 | ||
DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates | Q47691210 | ||
5 The determination of the partial specific volume of proteins by the mechanical oscillator technique | Q47906030 | ||
Importance of vancomycin loading doses in intermittent infusion regimens | Q49360115 | ||
Spermidine-Induced Attraction of Like-Charged Surfaces Is Correlated with the pH-Dependent Spermidine Charge: Force Spectroscopy Characterization. | Q49575239 | ||
Mucus thickness in the gastrointestinal tract of laboratory animals. | Q50261139 | ||
Attraction between negatively charged surfaces mediated by spherical counterions with quadrupolar charge distribution. | Q51861793 | ||
Globular structure of human ovulatory cervical mucus | Q58453292 | ||
Model for the structure of the gastric mucous gel | Q59059271 | ||
An optimized purification process for porcine gastric mucin with preservation of its native functional properties | Q63432017 | ||
Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections | Q64134814 | ||
Modification of central venous catheter flush solution improves in vitro antimicrobial activity | Q68047826 | ||
Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides | Q71058419 | ||
Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci | Q71071331 | ||
Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center | Q71879021 | ||
Some laboratory and clinical experiences with a new antibiotic, vancomycin | Q74268913 | ||
Comparison of procedures for the isolation of bovine submaxillary mucin | Q79086767 | ||
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets | Q83770914 | ||
Vancomycin resistance in gram-positive cocci | Q28284820 | ||
Vancomycin- and erythromycin-induced hearing loss in humans | Q30502734 | ||
A critical overview of ESEM applications in the biological field | Q33217441 | ||
Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. | Q33964245 | ||
Diffusion of macromolecules and virus-like particles in human cervical mucus | Q34176484 | ||
Drug transfer through mucus | Q34258345 | ||
Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma | Q34261744 | ||
Vancomycin: a history | Q34472263 | ||
Mucin-bacterial interactions in the human oral cavity and digestive tract | Q34503629 | ||
Structure, biochemistry and mechanism of action of glycopeptide antibiotics | Q34665729 | ||
Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature | Q34803713 | ||
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists | Q34910366 | ||
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens | Q35004943 | ||
Persistent staphylococcal bacteremia in an intravenous drug abuser | Q35573110 | ||
Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes | Q35603139 | ||
Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole | Q36208584 | ||
Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era | Q36831089 | ||
A polydisperse linear random coil model for the quaternary structure of pig colonic mucin | Q36866047 | ||
Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies | Q37024678 | ||
Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment | Q37211879 | ||
Raising the Alarmone: Within-Host Evolution of Antibiotic-Tolerant Enterococcus faecium | Q37712102 | ||
Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter | Q38061039 | ||
Vancomycin therapeutics and monitoring: a contemporary approach. | Q38062923 | ||
The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics | Q38305406 | ||
Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans. | Q38364959 | ||
The Nephrotoxicity of Vancomycin | Q38687487 | ||
The macrostructure of mucus glycoproteins in solution | Q38736364 | ||
Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci. | Q40210054 | ||
Application of recent advances in hydrodynamic methods for characterising mucins in solution | Q40287151 | ||
Ototoxicity of vancomycin and analogues | Q40776832 | ||
Heparin does not reduce catheter sepsis during total parenteral nutrition. | Q40818389 | ||
Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin | Q40824481 | ||
Diagnosis and treatment of Clostridium difficile colitis | Q40867217 | ||
Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? | Q41601830 | ||
Further evidence for a flexible and highly expanded spheroidal model for mucus glycoproteins in solution | Q41890985 | ||
The concentration-dependence of macromolecular parameters | Q41971526 | ||
Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems. | Q41998232 | ||
Full hydrodynamic reversibility of the weak dimerization of vancomycin and elucidation of its interaction with VanS monomers at clinical concentration | Q42079847 | ||
P433 | issue | 1 | |
P921 | main subject | vancomycin | Q424027 |
P304 | page(s) | 960 | |
P577 | publication date | 2020-01-22 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins | |
P478 | volume | 10 |
Search more.